Ester Hammond Receives 2015 Michael Fry Research Award

Ester Hammond is the recipient of the 2015 Michael Fry Research Award from the Radiation Research Society.

Ester is a CRUK Group Leader and Associate Professor in the CRUK/MRC Oxford Institute for Radiation Oncology. Her research is focused on investigating how tumours survive in conditions which include low oxygen (hypoxia), with the aim of targeting the hypoxic parts of tumours to improve cancer therapy.

Prestigious Royal College of Radiologists 2014 Gold Medal Awarded to Professor Gillies McKenna

Professor Gillies McKenna has been awarded the 2014 Gold Medal from The Royal College of Radiologists.  The medal is the highest honour the College has to bestow, and was awarded to Gillies for his ‘enormous national and international contribution to clinical oncology research and training.’

MErCuRIC study launched

Professor Tim Maughan from the Gray Institute for Radiation Oncology and Biology, University of Oxford is working on a new collaboration with the Queen’s University in Belfast who are leading a euro-wide research programme to find a new treatment for bowel cancer. This new research is being funded by the European Commission.

The MErCuRIC study, which was launched yesterday in Belfast, involves eight different countries and will look at two major genetic factors which make bowel cancer difficult to treat.

New trial of personalised cancer treatment begins in Oxford

The first human trial of a pioneering personalised cancer treatment developed at Oxford University will begin this week, with the potential to tackle a wide range of late-stage cancers.

A major challenge in drug development is that all cancer patients respond differently to treatment, making it difficult to know how best to treat each patient. For the first time, a phase I trial in Oxford will investigate not only a new drug, called CXD101, but also a new test to predict which patients could be successfully treated by this class of drug.

Major EPSRC Programme Grant to Support New Oxford Centre for Drug Delivery Devices

Cancer therapy drugs tend to achieve limited accumulation and poor penetration in tumours, reducing their effectiveness. For many years, the only methods used to improve drug uptake by tumours have been pharmacological, and these have had limited success.

Recent research at Oxford University has shown that physical mechanisms triggered by ultrasound, magnetic fields or shock waves can dramatically improve the delivery and penetration of existing and experimental drugs into tumours.


About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to RSS - News